Latest filing published 02 Jul 2025 for 3D Medicines Inc.. Read the official filing
Based on 15 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Zhu Pai appears in our data through filings on 3D Medicines Inc. shares, published by HKEX. Over a trading history stretching from 15 December 2022 to 30 June 2025, the count stands at 31 filings.
Both buying and selling appear: 16 purchases worth €236k, against 13 sales worth €203k. No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
Half of the purchases are above €10k and half below. Clusters matter here: 5 out of 15 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 15 purchases show a median change of -18.7%, with the price up in 0% of them. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 2 July 2025, reports a transaction in 3D Medicines Inc. The last purchase on record was published on 10 April 2024, which is 924 days ago. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 31 declarations